Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Kimura

Showing results (21-30 of 365) with videos related to

Pageof 37
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Molecular targeted therapy in lymphoid leukemias]Kensuke Kojima, Toshihiko Ando, Shinya Kimura
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 13, 2020
Urea Derivatives as Functional Molecules: Supramolecular Capsules, Supramolecular Polymers, Supramolecular Gels, Artificial Hosts, and CatalystsMasashi Yokoya, Shinya Kimura, Masamichi Yamanaka
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 24, 2005
[Detection of antibodies specific for blood group antigens A and B]Kimiko Yurugi, Shinya Kimura, Taira Maekawa
International Journal of Clinical Oncology|October 12, 2007
The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemiasTaira Maekawa, Eishi Ashihara, Shinya Kimura
Current Pharmaceutical Biotechnology|November 2, 2006
New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemiaShinya Kimura, Eishi Ashihara, Taira Maekawa
International Journal of Clinical Oncology|November 22, 2013
Ever-advancing chronic myeloid leukemia treatmentShinya Kimura, Toshihiko Ando, Kensuke Kojima
Internal Medicine (Tokyo, Japan)|August 6, 2025
Low Generic Drug Penetration for Expensive Oral Molecular Targeted Agents: An Experience with Generic Imatinib in JapanKeisuke Kidoguchi, Hiroshi Ureshino, Shinya Kimura
Cancers|November 25, 2023
Clinical PD-1/PD-L1 Blockades in Combination Therapies for LymphomasHiroo Katsuya, Junji Suzumiya, Shinya Kimura
Journal of Clinical and Experimental Hematopathology : JCEH|August 27, 2025
Advances in clonality analysis of human T-cell leukemia virus type 1-infected cells: from Southern blotting to high-throughput sequencingHiroo Katsuya, Yorifumi Satou, Shinya Kimura
Cryobiology|February 25, 2009
Importance of primary culture conditions for the development of rat ICSI embryos and long-term preservation of freeze-dried spermTakehito Kaneko, Shinya Kimura, Naomi Nakagata
Pageof 37

Showing results (21-30 of 365) with videos related to

Sort By:
Pageof 37
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Molecular targeted therapy in lymphoid leukemias]Kensuke Kojima, Toshihiko Ando, Shinya Kimura
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 13, 2020
Urea Derivatives as Functional Molecules: Supramolecular Capsules, Supramolecular Polymers, Supramolecular Gels, Artificial Hosts, and CatalystsMasashi Yokoya, Shinya Kimura, Masamichi Yamanaka
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 24, 2005
[Detection of antibodies specific for blood group antigens A and B]Kimiko Yurugi, Shinya Kimura, Taira Maekawa
International Journal of Clinical Oncology|October 12, 2007
The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemiasTaira Maekawa, Eishi Ashihara, Shinya Kimura
Current Pharmaceutical Biotechnology|November 2, 2006
New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemiaShinya Kimura, Eishi Ashihara, Taira Maekawa
International Journal of Clinical Oncology|November 22, 2013
Ever-advancing chronic myeloid leukemia treatmentShinya Kimura, Toshihiko Ando, Kensuke Kojima
Internal Medicine (Tokyo, Japan)|August 6, 2025
Low Generic Drug Penetration for Expensive Oral Molecular Targeted Agents: An Experience with Generic Imatinib in JapanKeisuke Kidoguchi, Hiroshi Ureshino, Shinya Kimura
Cancers|November 25, 2023
Clinical PD-1/PD-L1 Blockades in Combination Therapies for LymphomasHiroo Katsuya, Junji Suzumiya, Shinya Kimura
Journal of Clinical and Experimental Hematopathology : JCEH|August 27, 2025
Advances in clonality analysis of human T-cell leukemia virus type 1-infected cells: from Southern blotting to high-throughput sequencingHiroo Katsuya, Yorifumi Satou, Shinya Kimura
Cryobiology|February 25, 2009
Importance of primary culture conditions for the development of rat ICSI embryos and long-term preservation of freeze-dried spermTakehito Kaneko, Shinya Kimura, Naomi Nakagata
Pageof 37